Diseño sin título (3)Diseño sin título (3)

Dr. Silvia Sánchez-Ramón, Head of the Clinical Immunology Department at Hospital Ruber Internacional, has been appointed Head of the Clinical Immunology Department at La Paz University Hospital, one of Spain's leading referral hospitals. This appointment acknowledges her distinguished clinical, research, and academic career, as well as her leadership in the field of clinical immunology.

Dr. Sánchez-Ramón will combine this new responsibility with her current role as Head of the Clinical Immunology Department at Hospital Ruber Internacional, where she leads a highly specialized service dedicated to the diagnosis, treatment, and follow-up of patients with primary and secondary immunodeficiencies, autoimmune diseases, immune system disorders, and other highly complex conditions.

With an extensive professional background, Dr. Sánchez-Ramón has built a distinguished career in both clinical practice and research. She has participated in numerous national and international research projects, contributing significantly to advances in clinical immunology, immunosenescence, and immunodeficiency disorders. Her scientific work includes a substantial number of publications in high-impact peer-reviewed journals, as well as an active role in leading scientific societies and specialized working groups.

This appointment reflects the excellence of the professionals at Hospital Ruber Internacional and reinforces the hospital's commitment to highly specialized medicine driven by innovation, research, and personalized patient care.

For patients at Hospital Ruber Internacional, Dr. Sánchez-Ramón's continued leadership of the Clinical Immunology Department ensures ongoing access to the highest standard of care, supported by a physician with extensive expertise in the diagnosis and management of immune system disorders.

Hospital Ruber Internacional congratulates Dr. Silvia Sánchez-Ramón on this significant professional achievement and wishes her every success in this new stage of her career. We are confident that her leadership will continue to advance the field of clinical immunology and contribute to improving patient care.